drugset / Trial / NCT01454531
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the tolerability of AVANZ.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-03
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVANZ Phleum pratense | Unknown | 15000 unknown | Other |